Fosun Pharmaceutical bought Concert Pharmaceuticals Shanghai Fosun Pharmaceutical from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Shanghai Fosun Pharmaceutical

2196

HK$13.72

0.00%

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

Positive Technologies reported for 9 months of 2024 by RAS

11/7/24 POSI

Lukoil denies agreements to sell refinery to Bulgaria

11/7/24 LKOH

Trading on the stock market will start at noon

11/7/24 MOEX

Globaltrans to finalize repurchase of receipts

11/7/24 GLTR

Start of trading on the Stock Market is postponed

11/7/24 MOEX

Mikhail Kenin is looking for a buyer for his stake in Samolet

11/7/24 SMLT

Board of Directors of Renaissance Insurance recommended dividends

11/7/24 RENI

SFI's Board of Directors raised the dividend for the first 9 months of 2024

11/6/24 SFIN

Rosbank shares will cease trading from November 12

11/6/24 ROSB

Lambumiz reported for 9 months of 2024 by RAS

11/6/24 LMBZ